Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

Market Cap	17.09B +40.3%
Revenue (ttm)	2.62B +23.0%
Net Income	756.37M +68.4%
EPS	3.08 +68.7%
Shares Out	246.43M
PE Ratio	22.52
Forward PE	n/a
Dividend	1.70 (2.44%)
Ex-Dividend Date	n/a

Volume	6,063,883
Average Volume	5,680,849
Open	69.40
Previous Close	69.37
Day's Range	69.40 - 71.22
52-Week Range	49.83 - 85.65
Beta	0.39
RSI	54.72
Earnings Date	Apr 22, 2026

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicin...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 2,396
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2025, SHE:300573's revenue was 2.47 billion, an increase of 27.24% compared to the previous year's 1.94 billion. Earnings were 695.86 million, an increase of 105.84%.